These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35005816)

  • 41. Functional characterization of arylsulfatase B mutations in Indian patients with Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI).
    Uttarilli A; Pasumarthi D; Ranganath P; Dalal AB
    Gene; 2017 Jan; 599():19-27. PubMed ID: 27826022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Taiwan National Newborn Screening Program by Tandem Mass Spectrometry for Mucopolysaccharidoses Types I, II, and VI.
    Chan MJ; Liao HC; Gelb MH; Chuang CK; Liu MY; Chen HJ; Kao SM; Lin HY; Huang YH; Kumar AB; Chennamaneni NK; Pendem N; Lin SP; Chiang CC
    J Pediatr; 2019 Feb; 205():176-182. PubMed ID: 30409495
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epidemiology of mucopolysaccharidoses.
    Khan SA; Peracha H; Ballhausen D; Wiesbauer A; Rohrbach M; Gautschi M; Mason RW; Giugliani R; Suzuki Y; Orii KE; Orii T; Tomatsu S
    Mol Genet Metab; 2017 Jul; 121(3):227-240. PubMed ID: 28595941
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular characterization of mucopolysaccharidosis type IVA patients in the Andean region of Colombia.
    Pachajoa H; Acosta MA; Alméciga-Díaz CJ; Ariza Y; Diaz-Ordoñez L; Caicedo-Herrera G; Cuartas D; Nastasi-Catanese JA; Ramírez-Montaño D; Silva YK; Moreno L; Satizabal J; Garcia N; Montoya J; Prada C; Porras G; Velasco H; Candelo E
    Am J Med Genet C Semin Med Genet; 2021 Sep; 187(3):388-395. PubMed ID: 34542925
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Deep intronic variant in the ARSB gene as the genetic cause for Maroteaux-Lamy syndrome (MPS VI).
    Marek-Yagel D; Eliyahu A; Veber A; Shalva N; Philosoph AM; Barel O; Javasky E; Pode-Shakked B; Loewenthal N; Anikster Y; Staretz-Chacham O
    Am J Med Genet A; 2021 Dec; 185(12):3804-3809. PubMed ID: 34435740
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular analysis in a GALNS study cohort of 15 Tunisian patients: description of a novel mutation.
    Chkioua L; Khedhiri S; Hafsi H; Grissa O; Ben Turkia H; Miled A; Laradi S; Froissart R; Alif N
    Diagn Pathol; 2016 Jun; 11(1):51. PubMed ID: 27317439
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mucopolysaccharidosis III: Molecular basis and treatment.
    Spahiu L; Behluli E; Peterlin B; Nefic H; Hadziselimovic R; Liehr T; Temaj G
    Pediatr Endocrinol Diabetes Metab; 2021; 27(3):201-208. PubMed ID: 34743503
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mucopolysaccharidosis type VI: case report with first neonatal presentation with ascites fetalis and rapidly progressive cardiac manifestation.
    Honjo RS; Vaca ECN; Leal GN; Abellan DM; Ikari NM; Jatene MB; Martins AM; Kim CA
    BMC Med Genet; 2020 Feb; 21(1):37. PubMed ID: 32075597
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of pulmonary function impairments in patients with mucopolysaccharidoses--changes with age and treatment.
    Lin SP; Shih SC; Chuang CK; Lee KS; Chen MR; Niu DM; Chiu PC; Lin SJ; Lin HY
    Pediatr Pulmonol; 2014 Mar; 49(3):277-84. PubMed ID: 23401495
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A case of mucopolysaccharidosis type VI in a polish family. Importance of genetic testing and genotype-phenotype relationship in the diagnosis of mucopolysaccharidosis.
    Zapała B; Chmura O; Ciałowicz U; Solnica B; Krajewska-Włodarczyk M; Żuber Z
    Mol Genet Metab Rep; 2020 Dec; 25():100658. PubMed ID: 33163362
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Osteoimmunology in mucopolysaccharidoses type I, II, VI and VII. Immunological regulation of the osteoarticular system in the course of metabolic inflammation.
    Opoka-Winiarska V; Jurecka A; Emeryk A; Tylki-Szymańska A
    Osteoarthritis Cartilage; 2013 Dec; 21(12):1813-23. PubMed ID: 23954699
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutational analysis of 105 mucopolysaccharidosis type VI patients.
    Karageorgos L; Brooks DA; Pollard A; Melville EL; Hein LK; Clements PR; Ketteridge D; Swiedler SJ; Beck M; Giugliani R; Harmatz P; Wraith JE; Guffon N; Leão Teles E; Sá Miranda MC; Hopwood JJ
    Hum Mutat; 2007 Sep; 28(9):897-903. PubMed ID: 17458871
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mucopolysaccharidosis type VI: Identification of novel mutations on the arylsulphatase B gene in South American patients.
    Petry MF; Nonemacher K; Sebben JC; Schwartz IV; Azevedo AC; Burin MG; de Rezende AR; Kim CA; Giugliani R; Leistner-Segal S
    J Inherit Metab Dis; 2005; 28(6):1027-34. PubMed ID: 16435196
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA.
    Hendriksz CJ; Harmatz P; Beck M; Jones S; Wood T; Lachman R; Gravance CG; Orii T; Tomatsu S
    Mol Genet Metab; 2013; 110(1-2):54-64. PubMed ID: 23665161
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mucopolysaccharidosis IVA: identification of a common missense mutation I113F in the N-Acetylgalactosamine-6-sulfate sulfatase gene.
    Tomatsu S; Fukuda S; Cooper A; Wraith JE; Rezvi GM; Yamagishi A; Yamada N; Kato Z; Isogai K; Sukegawa K
    Am J Hum Genet; 1995 Sep; 57(3):556-63. PubMed ID: 7668283
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular diagnosis of patients affected by mucopolysaccharidosis: a multicenter study.
    Zanetti A; D'Avanzo F; Rigon L; Rampazzo A; Concolino D; Barone R; Volpi N; Santoro L; Lualdi S; Bertola F; Scarpa M; Tomanin R
    Eur J Pediatr; 2019 May; 178(5):739-753. PubMed ID: 30809705
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel splice site IDUA gene mutation in Tunisian pedigrees with hurler syndrome.
    Chkioua L; Boudabous H; Jaballi I; Grissa O; Turkia HB; Tebib N; Laradi S
    Diagn Pathol; 2018 May; 13(1):35. PubMed ID: 29843745
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Home sleep study characteristics in patients with mucopolysaccharidosis.
    Kasapkara ÇS; Tümer L; Aslan AT; Hasanoğlu A; Ezgü FS; Küçükçongar A; Tunca Z; Köktürk O
    Sleep Breath; 2014 Mar; 18(1):143-9. PubMed ID: 23690022
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular Characterization of a Novel Splicing Mutation underlying Mucopolysaccharidosis (MPS) type VI-Indirect Proof of Principle on Its Pathogenicity.
    Coutinho MF; Encarnação M; Matos L; Silva L; Ribeiro D; Santos JI; Prata MJ; Vilarinho L; Alves S
    Diagnostics (Basel); 2020 Jan; 10(2):. PubMed ID: 31973102
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Mucopolysaccharidosis type I in the Cuban population].
    Menéndez-Sainz C; Zaldívar-Muñoz C; González-Quevedo A
    Rev Neurol; 2003 Sep 16-30; 37(6):525-8. PubMed ID: 14533069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.